US Bill Seeks To Eliminate Biosimilar Interchangeability Trial Burden

‘Biosimilar Red Tape Elimination Act’ Would Remove Need For Switching Studies

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".